BIIB Jan 2023 385.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 07:46AM EDT. Market open.
| Previous close | 18.80 |
| Open | 18.80 |
| Bid | 7.00 |
| Ask | 14.90 |
| Strike | 385.00 |
| Expiry date | 2023-01-20 |
| Day's range | 18.80 - 18.80 |
| Contract range | N/A |
| Volume | |
| Open interest | 6 |
- Zacks
How Are Biotech ETFs Reacting to These Q1 Earnings Releases?
Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.
- Motley Fool
Is This Growth Stock Defeated After Collapsing 22% in a Year?
With its shares down by more than 22% in the last 12 months, it's clear that Biogen (NASDAQ: BIIB) isn't the high-flying growth stock that it used to be. Since its failed attempt over the last year to get its fiercely criticized Alzheimer's disease drug Aduhelm approved for sale, the company's troubles have turned from bad to worse. Revenue and earnings from its core drug products are both down sharply over the last three years.
- Zacks
The Zacks Analyst Blog Highlights Oracle, Union Pacific, Ford Motor, Biogen and Expedia Group
Oracle, Union Pacific, Ford Motor, Biogen and Expedia Group have been included in this Analyst Blog.
© 2022 Yahoo. All rights reserved.
